{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:52:09Z","timestamp":1780761129679,"version":"3.54.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102737"],"award-info":[{"award-number":["82102737"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373105"],"award-info":[{"award-number":["82373105"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wuxi \"Taihu talent plan\" for excellent medical expert team","award":["Grant No. 2021-9"],"award-info":[{"award-number":["Grant No. 2021-9"]}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20251759"],"award-info":[{"award-number":["BK20251759"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"name":"key research and development program of Jiangsu province","award":["BE2023834"],"award-info":[{"award-number":["BE2023834"]}]},{"name":"high-level startup fund of Nanjing Medical University","award":["KY109RC2019010"],"award-info":[{"award-number":["KY109RC2019010"]}]},{"name":"Joint Open Research Fund of Suzhou Institute of Nanotechnology and Nano-bionics & Jiangsu Province Hospital, the Medical Engineering Translational Fund of Jiangsu Province Hospital","award":["NM202404"],"award-info":[{"award-number":["NM202404"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03875-0","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T19:34:44Z","timestamp":1765136084000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tumor targeting dendritic nanocarrier with immunogenic cell death inducing and TIGIT blockade for synergistic chemo-immunotherapy against TNBC"],"prefix":"10.1186","volume":"23","author":[{"given":"Jia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengpeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haisi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huae","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,7]]},"reference":[{"key":"3875_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3875_CR2","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.cell.2023.01.040","volume":"186","author":"E Nolan","year":"2023","unstructured":"Nolan E, Lindeman GJ, Visvader JE. Deciphering breast cancer: from biology to the clinic. Cell. 2023;186:1708\u201328.","journal-title":"Cell"},{"key":"3875_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","volume":"22","author":"L Yin","year":"2020","unstructured":"Yin L, Duan JJ, Bian XW, Yu SC. Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res. 2020;22:61.","journal-title":"Breast Cancer Res"},{"key":"3875_CR4","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1002\/cncr.31272","volume":"124","author":"MJ Kwa","year":"2018","unstructured":"Kwa MJ, Adams S. Checkpoint inhibitors in triple-negative breast cancer (TNBC): where to go from here. Cancer. 2018;124:2086\u2013103.","journal-title":"Cancer"},{"key":"3875_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","volume":"23","author":"G Oliveira","year":"2023","unstructured":"Oliveira G, Wu CJ. Dynamics and specificities of T cells in cancer immunotherapy. Nat Rev Cancer. 2023;23:295\u2013316.","journal-title":"Nat Rev Cancer"},{"key":"3875_CR6","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","volume":"184","author":"G Morad","year":"2021","unstructured":"Morad G, Helmink BA, Sharma P, Wargo JA. Hallmarks of response, resistance, and toxicity to immune checkpoint blockade. Cell. 2021;184:5309\u201337.","journal-title":"Cell"},{"key":"3875_CR7","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1158\/2326-6066.CIR-17-0150","volume":"5","author":"NK Brockwell","year":"2017","unstructured":"Brockwell NK, Owen KL, Zanker D, Spurling A, Rautela J, Duivenvoorden HM, et al. Neoadjuvant interferons: critical for effective PD-1-based immunotherapy in TNBC. Cancer Immunol Res. 2017;5:871\u201384.","journal-title":"Cancer Immunol Res"},{"key":"3875_CR8","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/s41551-021-00799-6","volume":"5","author":"G Xue","year":"2021","unstructured":"Xue G, Wang ZY, Zheng NB, Fang J, Mao CQ, Li XY, et al. Elimination of acquired resistance to PD-1 blockade via the concurrent depletion of tumour cells and immunosuppressive cells. Nat Biomed Eng. 2021;5:1306\u201319.","journal-title":"Nat Biomed Eng"},{"key":"3875_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/ni.1674","volume":"10","author":"X Yu","year":"2009","unstructured":"Yu X, Harden K, Gonzalez LC, Francesco M, Chiang E, Irving B, et al. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat Immunol. 2009;10:48\u201357.","journal-title":"Nat Immunol"},{"key":"3875_CR10","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41590-018-0132-0","volume":"19","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Bi JC, Zheng XD, Chen YY, Wang H, Wu HY, et al. Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity. Nat Immunol. 2018;19:723\u201332.","journal-title":"Nat Immunol"},{"key":"3875_CR11","doi-asserted-by":"publisher","first-page":"15114","DOI":"10.1002\/anie.202002783","volume":"59","author":"XM Zhou","year":"2020","unstructured":"Zhou XM, Zuo C, Li WQ, Shi WW, Zhou XW, Wang HF, et al. A novel D-peptide identified by mirror-image phage display blocks TIGIT\/PVR for cancer immunotherapy. Angew Chem Int Ed. 2020;59:15114\u2013 18.","journal-title":"Angew Chem Int Ed"},{"key":"3875_CR12","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1056\/NEJMoa2112651","volume":"386","author":"P Schmid","year":"2022","unstructured":"Schmid P, Cortes J, Dent R, Pusztai L, McArthur H, Kimmel S, et al. Event-free survival with pembrolizumab in early triple-negative breast cancer. N Engl J Med. 2022;386:556\u201367.","journal-title":"N Engl J Med"},{"key":"3875_CR13","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1021\/acsnano.3c11445","volume":"18","author":"S Kwon","year":"2024","unstructured":"Kwon S, Meng FF, Tamam H, Gadalla HH, Wang JP, Dong BY, et al. Systemic delivery of paclitaxel by find-me nanoparticles activates antitumor immunity and eliminates tumors. ACS Nano. 2024;18:3681\u201398.","journal-title":"ACS Nano"},{"key":"3875_CR14","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/s41467-024-44963-3","volume":"15","author":"ZQ Zhang","year":"2024","unstructured":"Zhang ZQ, Xu XX, Du JW, Chen X, Xue YE, Zhang JQ, et al. Redox-responsive polymer micelles co-encapsulating immune checkpoint inhibitors and chemotherapeutic agents for glioblastoma therapy. Nat Commun. 2024;15:1118.","journal-title":"Nat Commun"},{"key":"3875_CR15","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.jconrel.2021.12.002","volume":"341","author":"XY Qiu","year":"2022","unstructured":"Qiu XY, Qu Y, Guo BB, Zheng H, Meng FH, Zhong ZY. Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer. J Control Release. 2022;341:498\u2013510.","journal-title":"J Control Release"},{"key":"3875_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cell.2005.08.032","volume":"123","author":"SJ Gardai","year":"2005","unstructured":"Gardai SJ, McPhillips KA, Frasch SC, Janssen WJ, Starefeldt A, Murphy-Ullrich JE, et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell. 2005;123:321\u201334.","journal-title":"Cell"},{"key":"3875_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nm1523","volume":"13","author":"M Obeid","year":"2007","unstructured":"Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med. 2007;13:54\u201361.","journal-title":"Nat Med"},{"key":"3875_CR18","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nature08296","volume":"461","author":"MR Elliott","year":"2009","unstructured":"Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SF, et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature. 2009;461:282\u201386.","journal-title":"Nature"},{"key":"3875_CR19","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.immuni.2013.03.003","volume":"38","author":"Y Ma","year":"2013","unstructured":"Ma Y, Adjemian S, Mattarollo SR, Yamazaki T, Aymeric L, Yang H, et al. Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity. 2013;38:729\u201341.","journal-title":"Immunity"},{"key":"3875_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/cdd.2013.72","volume":"21","author":"T Yamazaki","year":"2014","unstructured":"Yamazaki T, Hannani D, Poirier-Colame V, Ladoire S, Locher C, Sistigu A, et al. Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists. Cell Death Differ. 2014;21:69\u201378.","journal-title":"Cell Death Differ"},{"key":"3875_CR21","doi-asserted-by":"publisher","first-page":"9972","DOI":"10.1021\/acsnano.2c11964","volume":"17","author":"RR Zheng","year":"2023","unstructured":"Zheng RR, Zhao LP, Huang CY, Cheng H, Yang N, Chen ZX, et al. Paraptosis inducer to effectively trigger immunogenic cell death for metastatic tumor immunotherapy with IDO inhibition. ACS Nano. 2023;17:9972\u201386.","journal-title":"ACS Nano"},{"key":"3875_CR22","first-page":"5828","volume":"18","author":"YD Wang","year":"2024","unstructured":"Wang YD, Li HD, Niu GM, Li YT, Huang ZQ, Cheng SQ, et al. Boosting sono-immunotherapy of prostate carcinoma through amplifying domino-effect of mitochondrial oxidative stress using biodegradable cascade-targeting nanocomposites. ACS Nano. 2024;18:5828\u201346.","journal-title":"ACS Nano"},{"key":"3875_CR23","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1126\/science.1208347","volume":"334","author":"M Michaud","year":"2011","unstructured":"Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma YT, Pellegatti P, et al. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science. 2011;334:1573\u201377.","journal-title":"Science"},{"key":"3875_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.phytochem.2017.11.002","volume":"145","author":"Z Wang","year":"2018","unstructured":"Wang Z, Zhao SM, Hu YY, Feng L, Zhao LM, Di YT, et al. Rubipodanones A-D, naphthohydroquinone dimers from the roots and rhizomes of Rubia Podantha. Phytochemistry. 2018;145:153\u201360.","journal-title":"Phytochemistry"},{"key":"3875_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/cells8121593","volume":"8","author":"J Wang","year":"2019","unstructured":"Wang J, Li L, Wang J, Song LH, Tan NH, Wang Z. Natural naphthohydroquinone dimer Rubioncolin C exerts anti-tumor activity by inducing apoptotic and autophagic cell death and inhibiting the NF-\u03baB and Akt\/mTOR\/P70S6K pathway in human cancer cells. Cells. 2019;8:1593.","journal-title":"Cells"},{"key":"3875_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114184","volume":"277","author":"L Li","year":"2021","unstructured":"Li L, Wang J, Feng L, Fan JT, Wang J, Tan NH, et al. Rubioncolin C, a natural naphthohydroquinone dimer isolated from Rubia yunnanensis, inhibits the proliferation and metastasis by inducing ROS-mediated apoptotic and autophagic cell death in triple-negative breast cancer cells. J Ethnopharmacol. 2021;277:114184.","journal-title":"J Ethnopharmacol"},{"key":"3875_CR27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41556-018-0256-3","volume":"21","author":"I Keblikoglou","year":"2019","unstructured":"Keblikoglou I, Cianciaruso C, Guc E, Squadrito ML, Spring LM, Tazzyman S, et al. Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models. Nat Cell Biol. 2019;21:190\u2013202.","journal-title":"Nat Cell Biol"},{"key":"3875_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202000392","volume":"9","author":"Z Zheng","year":"2020","unstructured":"Zheng Z, Lang TQ, Huang X, Wang GR, Lee RJ, Teng LS, et al. Calcitriol-loaded dual-pH-sensitive micelle counteracts pro-metastasis effect of paclitaxel in triple-negative breast cancer therapy. Adv Healthc Mater. 2020;9:2000392.","journal-title":"Adv Healthc Mater"},{"key":"3875_CR29","doi-asserted-by":"publisher","first-page":"10206","DOI":"10.1021\/acsnano.3c00326","volume":"17","author":"S Ning","year":"2023","unstructured":"Ning S, Lyu M, Zhu D, Lam JWY, Huang Q, Zhang T, et al. Type-I AIE photosensitizer loaded biomimetic system boosting Cuproptosis to inhibit breast cancer metastasis and rechallenge. ACS Nano. 2023;17:10206\u201317.","journal-title":"ACS Nano"},{"key":"3875_CR30","doi-asserted-by":"publisher","first-page":"7433","DOI":"10.1021\/jacs.4c15534","volume":"147","author":"S Ning","year":"2025","unstructured":"Ning S, Shangguan P, Zhu X, Ou X, Wang K, Suo M, et al. Pyridinium rotor strategy toward a robust photothermal agent for STING activation and multimodal image-guided immunotherapy for triple-negative breast cancer. J Am Chem Soc. 2025;147:7433\u201344.","journal-title":"J Am Chem Soc"},{"key":"3875_CR31","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1021\/bc015525a","volume":"13","author":"M Ohsaki","year":"2002","unstructured":"Ohsaki M, Okuda T, Wada A, Hirayama T, Niidome T, Aoyagi H. In vitro gene transfection using dendritic poly(L-lysine). Bioconjug Chem. 2002;13:510\u201317.","journal-title":"Bioconjug Chem"},{"key":"3875_CR32","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0142-9612(03)00542-8","volume":"25","author":"T Okuda","year":"2004","unstructured":"Okuda T, Sugiyama A, Niidome T, Aoyagi H. Characters of dendritic poly(L-lysine) analogues with the terminal lysines replaced with arginines and histidines as gene carriers in vitro. Biomaterials. 2004;25:537\u201344.","journal-title":"Biomaterials"},{"key":"3875_CR33","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jconrel.2006.09.012","volume":"116","author":"T Okuda","year":"2006","unstructured":"Okuda T, Kawakami S, Akimoto N, Nidome T, Yamashita F, Hashida M. PEGylated lysine dendrimers for tumor-selective targeting after intravenous injection in tumor-bearing mice. J Control Release. 2006;116:330\u201336.","journal-title":"J Control Release"},{"key":"3875_CR34","doi-asserted-by":"publisher","first-page":"2307263","DOI":"10.1002\/adma.202307263","volume":"36","author":"Y Li","year":"2024","unstructured":"Li Y, Wu Y, Zhang Y, Zhang H, Ding H, Ren H, et al. Dendritic nanomedicine with boronate bonds for augmented chemo-immunotherapy via synergistic modulation of tumor immune microenvironment. Adv Mater. 2024;36:2307263.","journal-title":"Adv Mater"},{"key":"3875_CR35","first-page":"20143","volume":"16","author":"YY Wen","year":"2024","unstructured":"Wen YY, Li KM, Ni MN, Jiang MH, Wu HS, Yu QQ, et al. Dendritic polylysine with Paclitaxel and triptolide codelivery for enhanced cancer ferroptosis through the accumulation of ROS. ACS Appl Mater Interfaces. 2024;16:20143\u201356.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3875_CR36","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1021\/acs.jnatprod.3c00125","volume":"86","author":"L Feng","year":"2023","unstructured":"Feng L, Shang RR, Wang XJ, Li L, Li X, Gong YX, et al. The natural alkaloid (-)-N-Hydroxyapiosporamide suppresses colorectal tumor progression as an NF-\u03baB pathway inhibitor by targeting the TAK1-TRAF6 complex. J Nat Prod. 2023;86:1449\u201362.","journal-title":"J Nat Prod"},{"key":"3875_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202404956","volume":"34","author":"K Li","year":"2024","unstructured":"Li K, Li X, Wu J, Wu H, Wu M, Zhou Y, et al. A dual enhancing strategy of novel nanovaccine based on TIM3 silencing nanoadjuvants and desialylated cancer cell membrane antigens for personalized vaccination immunotherapy of cancer. Adv Funct Mater. 2024;34:2404956.","journal-title":"Adv Funct Mater"},{"key":"3875_CR38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.addr.2019.04.008","volume":"143","author":"ND Donahue","year":"2019","unstructured":"Donahue ND, Acar H, Wilhelm S. Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine. Adv Drug Deliv Rev. 2019;143:68\u201396.","journal-title":"Adv Drug Deliv Rev"},{"key":"3875_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmatsci.2022.100961","volume":"128","author":"MA Islam","year":"2022","unstructured":"Islam MA, Park TE, Firdous J, Li HS, Jimenez Z, Lim M, et al. Essential cues of engineered polymeric materials regulating gene transfer pathways. Prog Mater Sci. 2022;128:100961.","journal-title":"Prog Mater Sci"},{"key":"3875_CR40","doi-asserted-by":"publisher","first-page":"0148","DOI":"10.34133\/research.0148","volume":"6","author":"C Qiu","year":"2023","unstructured":"Qiu C, Xia F, Zhang J, Shi Q, Meng Y, Wang C, et al. Advanced strategies for overcoming endosomal\/lysosomal barrier in nanodrug delivery. Research. 2023;6:0148.","journal-title":"Research"},{"key":"3875_CR41","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010;70:440.","journal-title":"Cancer Res"},{"key":"3875_CR42","doi-asserted-by":"publisher","first-page":"29613","DOI":"10.1021\/acsami.2c06063","volume":"14","author":"J Wang","year":"2022","unstructured":"42. Wang J, Wu HS, Zhao QQ, Zou YF, Ding D, Yin HT, et al. Aggregation-induced emission photosensitizer synergizes photodynamic therapy and the inhibition of the NF-\u03baB signaling pathway to overcome hypoxia in breast cancer. ACS Appl Mater Interfaces. 2022;14:29613\u201325.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3875_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121799","volume":"289","author":"H Jiang","year":"2022","unstructured":"Jiang H, Fu H, Guo YD, Hu P, Shi JL. Evoking tumor associated macrophages by mitochondria-targeted magnetothermal immunogenic cell death for cancer immunotherapy. Biomaterials. 2022;289:121799.","journal-title":"Biomaterials"},{"key":"3875_CR44","doi-asserted-by":"publisher","first-page":"102838","DOI":"10.1016\/j.nantod.2025.102838","volume":"65","author":"T Moorthy","year":"2025","unstructured":"Moorthy T, Chen CK, Liu ZH, Yalamandala BN, Huynh TMH, Iao HM, et al. Wireless chargeable gold yarnball-mediated mitochondrial depolarization for dendritic cell detainment in programmed brain tumor immunotherapy. Nano Today. 2025;65:102838.","journal-title":"Nano Today"},{"key":"3875_CR45","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrc3380","volume":"12","author":"DV Krysko","year":"2012","unstructured":"Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer. 2012;12:860\u201375.","journal-title":"Nat Rev Cancer"},{"key":"3875_CR46","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3875_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112260","volume":"194","author":"S Mondal","year":"2020","unstructured":"Mondal S, Adhikari N, Banerjee S, Amin SA, Jha T. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: a minireview. Eur J Med Chem. 2020;194:112260.","journal-title":"Eur J Med Chem"},{"key":"3875_CR48","doi-asserted-by":"publisher","first-page":"9062","DOI":"10.1158\/0008-5472.CAN-10-1825","volume":"70","author":"R Zappasodi","year":"2010","unstructured":"Zappasodi R, Pupa SM, Ghedini GC, Bongarzone I, Magni M, Cabras AD, et al. Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death. Cancer Res. 2010;70:9062\u201372.","journal-title":"Cancer Res"},{"key":"3875_CR49","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1021\/acsnano.4c09525","volume":"19","author":"MR Chiang","year":"2025","unstructured":"Chiang MR, Hsu CW, Pan WC, Tran NT, Lee YS, Chiang WH, et al. Reprogramming dysfunctional dendritic cells by a versatile catalytic dual oxide antigen-captured nanosponge for remotely enhancing lung metastasis immunotherapy. ACS Nano. 2025;19:2117\u2013135.","journal-title":"ACS Nano"},{"key":"3875_CR50","doi-asserted-by":"publisher","first-page":"146276","DOI":"10.1016\/j.cej.2023.146276","volume":"476","author":"H Chen","year":"2023","unstructured":"Chen H, Luo X, Huang Q, Liu Z, Lyu M, Chen D, et al. Platelet membrane fusion liposome loaded with type I AIE photosensitizer to induce chemoresistance cancer pyroptosis and Immunogenic cell death for enhancing cancer immunotherapy. Chem Eng J. 2023;476:146276.","journal-title":"Chem Eng J"},{"key":"3875_CR51","doi-asserted-by":"publisher","first-page":"25134","DOI":"10.1021\/acsnano.5c05395","volume":"19","author":"TMH Huynh","year":"2025","unstructured":"Huynh TMH, Huang PX, Wang KL, Tran NT, Iao HM, Pan WC, et al. Reprogramming immunodeficiency in lung metastases via PD-L1 siRNA delivery and antigen capture of nanosponge-mediated dendritic cell modulation. ACS Nano. 2025;19:25134\u201353.","journal-title":"ACS Nano"},{"key":"3875_CR52","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","volume":"21","author":"S Jhunjhunwala","year":"2021","unstructured":"Jhunjhunwala S, Hammer C, Delamarre L. Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion. Nat Rev Cancer. 2021;21:298\u2013312.","journal-title":"Nat Rev Cancer"},{"key":"3875_CR53","doi-asserted-by":"publisher","first-page":"18712","DOI":"10.1021\/acsnano.4c06183","volume":"18","author":"BN Yalamandala","year":"2024","unstructured":"Yalamandala BN, Chen YJ, Lin YH, Huynh TMH, Chiang WH, Chou TC, et al. A self-cascade penetrating brain tumor immunotherapy mediated by near-infrared II cell membrane-disrupting nanoflakes via detained dendritic cells. ACS Nano. 2024;18:18712\u2013728.","journal-title":"ACS Nano"},{"key":"3875_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202401806","volume":"34","author":"TMH Huynh","year":"2024","unstructured":"Huynh TMH, Luc VS, Chiang MR, Weng WH, Chang CW, Chiang WH, et al. Programmed lung metastasis immunotherapy via cascade-responsive cell membrane-mimetic copolymer-wrapped nanoraspberry-mediated elesclomol-copper delivery. Adv Funct Mater. 2024;34:2401806.","journal-title":"Adv Funct Mater"},{"key":"3875_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202406178","volume":"21","author":"BN Yalamandala","year":"2025","unstructured":"Yalamandala BN, Moorthy T, Liu ZH, Huynh TMH, Iao HM, Pan WC, et al. A self-cascading catalytic therapy and antigen capture scaffold-mediated T cells augments for postoperative brain immunotherapy. Small. 2025;21:e2406178.","journal-title":"Small"},{"key":"3875_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202108971","volume":"32","author":"YH Zheng","year":"2022","unstructured":"Zheng YH, Han YB, Wang TT, Liu HH, Sun Q, Hu SJ, et al. Reprogramming tumor-associated macrophages via ROS-mediated novel mechanism of ultra-small Cu2-xSe nanoparticles to enhance anti-tumor immunity. Adv Funct Mater. 2022;32:2108971.","journal-title":"Adv Funct Mater"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03875-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03875-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03875-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T04:14:46Z","timestamp":1765167286000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03875-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,7]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3875"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03875-0","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,7]]},"assertion":[{"value":"27 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"759"}}